Trials / Completed
CompletedNCT05434390
A Latino MSM Focused Pre-Exposure Prophylaxis Uptake Intervention
Evaluating the Feasibility and Acceptability of a Latino MSM Focused PrEP Uptake Intervention
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- University of California, Los Angeles · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The clinical study will evaluate the feasibility and acceptability of a culturally tailored behavioral intervention to improve uptake of pre-exposure prophylaxis for HIV prevention among at-risk Latino men who have sex with men.
Detailed description
The clinical study will evaluate the feasibility and acceptability of a brief small group and peer navigation behavioral intervention to improve uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among at-risk Latino men who have sex with men. The brief intervention consists of 4 small group sessions with concurrent peer navigation and counseling. Study participants will be randomized to either an intervention or control condition. Participants in the control condition will receive usual care for PrEP promotion (i.e., referral to PrEP services). The study will determine the feasibility and acceptability of the intervention among Latino men who have sex with men and assess the preliminary impact of the intervention compared to control condition in facilitating PrEP uptake.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Estoy PrEParado/ I am PrEPared intervention | Participants will receive an Information, Motivation, and Behavioral skills model PrEP intervention tailored for mixed immigrant status Latino men who have sex with men |
| BEHAVIORAL | Usual Care | Participants will be offered PrEP navigation services as part of usual care at the study site. |
Timeline
- Start date
- 2022-10-03
- Primary completion
- 2024-08-31
- Completion
- 2024-08-31
- First posted
- 2022-06-28
- Last updated
- 2026-04-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05434390. Inclusion in this directory is not an endorsement.